Sara Frances Franco, LPN in Lakin, KS - Licensed Practical Nurse

Sara Frances Franco, LPN is a Licensed Practical Nurse based in Lakin, Kansas. Sara Frances Franco is licensed to practice in Kansas (license number 51666) and her current practice location is 607 Court Pl, Lakin, Kansas. She can be reached at her office (for appointments etc.) via phone at (620) 355-7836.

NPI number for Sara Frances Franco is 1457093395 and her current mailing address is 10237 W 21st St N Apt C35, Wichita, Kansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1457093395.

Contact Information

	Sara Frances Franco, LPN
	607 Court Pl, Lakin, KS 67860-9704
	(620) 355-7836
	Not Available

Provider's Profile

Full Name	Sara Frances Franco
Gender	Female
Speciality	Licensed Practical Nurse
Location	607 Court Pl, Lakin, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1457093395
Provider Enumeration Date: 04/11/2022
Last Update Date: 04/11/2022

Medical Identifiers

Medical identifiers for Sara Frances Franco such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1457093395	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	51666 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sara Frances Franco is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sara Frances Franco, LPN 10237 W 21st St N Apt C35, Wichita, KS 67205-1825 Ph: (620) 214-0649	Sara Frances Franco, LPN 607 Court Pl, Lakin, KS 67860-9704 Ph: (620) 355-7836

News Archive

Genta announces initial trial results for novel drug for bone disease

Genta Incorporated has announced the release of final results from the Company's Phase 1 clinical trial of G4544, a proprietary small molecule that is intended as a treatment for diseases associated with accelerated bone loss. Results showed that the drug was very well-tolerated, and that blood levels were achieved in a range that is known to be clinically bioactive. The data were featured in a poster session at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on Saturday, May 31, 2008.

High levels of physician verbal abuse are associated with more negative work environments

A recent study by the RN Work Project found that newly licensed registered nurses (NLRNs) who were verbally abused by nursing colleagues reported lower job satisfaction, unfavorable perceptions of their work environment, and greater intent to leave their current jobs.

Prevalence of cirrhosis may climb among older Americans

Older patients with cirrhosis have significant functional disability, require twice the amount of informal caregiving, and contribute added strain on the health care system, according to U-M research published in Hepatology.

Tenn.-based hospital company to pay $98 million to settle improper billing claims

Community Health Systems and the federal Justice Department announced the settlement Monday. In other hospital news, Tenet says its financial outlook is improving.

Sara Frances Franco, LPN - Licensed Practical Nurse in Lakin, KS